Evonik aligns two business lines with new growth strategy

Businesses outside core areas are to be sold or discontinued

16-Oct-2024 - Evonik is reorganizing two business lines to strengthen their growth prospects. Coating & Adhesive Resins and Health Care will focus on and concentrate future investments in their respective core businesses. The remaining businesses outside these cores are to be sold to new owners or incorporated ...

Animal-free cell therapy from Aachen secures global growth

PL BioScience closes Series A financing in the amount of 7.8 million euros

09-Aug-2024 - PL BioScience GmbH has successfully completed a Series A financing round. The growth financing round attracted significant investments from AVANT BIO (New York), LePure Biotech (Shanghai), b.value AG (Dortmund) and better ventures (Munich). The four partners contribute their experience in deep ...

Merck Invests More Than € 300 Million in New Life Science Research Center in Germany

Research center to accelerate biopharmaceutical product development

26-Apr-2024 - Merck, a leading science and technology company, is investing more than €300 million in a new research center at its global headquarters in Darmstadt, Germany. In the Advanced Research Center, the Life Science business sector will research solutions for manufacturing antibodies, mRNA ...

Capricorn Scientific and ExcellGene Form Strategic Partnership to Support Biotech Industries

This customer-oriented approach is dedicated to accelerating the biotech journey from R&D up to clinical production

29-Feb-2024 - Capricorn Scientific GmbH and ExcellGene SA have established a strategic partnership within the biotechnology sector. Applying their collective expertise and capabilities, the collaboration seeks to help customers by optimizing processes, developing products, and offering solutions in ...

IUTA and Green Elephant win second LABVOLUTION AWARD

11-May-2023 - Making everyday laboratory processes run more smoothly, increasing sustainability, improving efficiency and reducing costs – this is what the second LABVOLUTION AWARD was all about. The award ceremony took place on 10 May, during the second day. Alongside the Institut für Umwelt & Energie, ...

Thermo Fisher Scientific announces collaboration with Celltrio

Unlock fully automated cell line production

08-Feb-2023 - Thermo Fisher Scientific and Celltrio, a manufacturer of robotics-based solutions for the life sciences industry, have announced their collaboration to bring a fully automated cell culture system to biotherapeutics customers. The collaboration will integrate the Thermo Scientific Momentum ...

Merck acquires Erbi Biosystems

Allows Merck to offer full range of bioreactors, from 2ml to 2000L

08-Dec-2022 - Merck has acquired Massachusetts-based Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology, known as the “Breez™”. The deal strengthens Merck’s upstream portfolio in therapeutic proteins by enabling scalable cell-based perfusion bioreactor processes from 2ml to 2000L ...

Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility

The new facility is planned to ensure that FUJIFILM Irvine Scientific can meet increasing market demands

23-Nov-2022 - FUJIFILM Corporation announced a $188 million investment to establish a cell culture media manufacturing facility in Research Triangle Park (RTP), North Carolina, USA. The new site will be operated by FUJIFILM Irvine Scientific, Inc., a subsidiary of FUJIFILM Corporation, and a world leader in ...

faCellitate, a BASF spin-off, raises 3.7 million euros in first financing round

First product facilitates reliable and reproducible 3D cell cultivation

12-Sep-2022 - Mannheim-based life science startup faCellitate has successfully raised 3.7 million Euro in its closing of seed funding. On board are well-known investors such as SARSTEDT, HTGF, R3 Consulting, ROI Verwaltungsgesellschaft, ARVE Capital and Chemovator. The faCellitate team under the leadership of ...

Sartorius to acquire Albumedix

Sartorius will acquire all outstanding shares of Albumedix Ltd. for approximately £415 million

10-Aug-2022 - The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire 100 percent of Albumedix Ltd. from private investors. The Nottingham, UK-based company provides best-in-class recombinant albumin-based solutions. Recombinant human albumin is an ...